SCHEMBL18677640

SCHEMBL18677640

Cc1cc(C(C)(C)C)cc(N(C)C)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.43
HTR1D P28221 6/20 0.38
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
CYP2C19 P33261 3/20 0.35
ALDH1A1 P00352 3/20 0.35
HTR1B P28222 4/20 0.34
KDM4E B2RXH2 1/20 0.33
TSHR P16473 3/20 0.33
HTR1A P08908 2/20 0.33
ADRA2A P08913 2/20 0.33
ADRA2B P18089 2/20 0.33
ADRA2C P18825 2/20 0.33
CYP2D6 P10635 2/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
DRD2 P14416 1/20 0.33
CHRM3 P20309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18677639 0.78 CYP2C19 (0.46) POLBHTR1DGABRA1GABRB2CYP2C19
SCHEMBL8664743 0.77 POLB (0.57) POLBHTR1DGABRA1GABRB2CYP2C19
SCHEMBL19240329 0.76 KDM4E (0.43) POLBHTR1DCYP2C19ALDH1A1HTR1B
SCHEMBL7699037 0.73 RAPGEF4 (0.36) ALDH1A1KDM4ETSHRLMNAMAPT
SCHEMBL16437229 0.73 ESR1 (0.50) POLBHTR1DCYP2C19ALDH1A1HTR1B
Hydrochloric Acid SCHEMBL6906567 0.71 POLB (0.38) POLBHTR1DKDM4E
Hydrochloric Acid SCHEMBL6906559 0.71 POLB (0.34) POLBHTR1DHTR1BKDM4ETSHR
SCHEMBL6382828 0.70
SCHEMBL5051891 0.70 POLB (0.50) POLBHTR1DGABRA1GABRB2CYP2C19
SCHEMBL6906564 0.70 POLB (0.33) POLBHTR1DKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11034684-B2 Isoxazole analogs as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2021-06-15 US disclosed
US-10450306-B2 Isoxazole analogs as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2019-10-22 US disclosed
US-20180099957-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. 2018-04-12 US disclosed
WO-2017050870-A9 SYNTHESIS OF SUBSTITUTED AMIDOBENZOATE COMPOUNDS, THE COMPOUNDS OBTAINED AND THE USE THEREOF AS PHTHALATE FREE INTERNAL ELECTRON DONOR FOR POLYMERIZATION OF OLEFINS SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-01-25 WO disclosed
WO-2017050870-A1 SYNTHESIS OF SUBSTITUTED AMIDOBENZOATE COMPOUNDS, THE COMPOUNDS OBTAINED AND THE USE THEREOF AS PHTHALATE FREE INTERNAL ELECTRON DONOR FOR POLYMERIZATION OF OLEFINS SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2017-03-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450306-B2 Isoxazole analogs as FXR agonists and methods of use thereof GPBAR1, SLC10A1, NR1H4 POLB 3719/4885HTR1D 2977/4885GABRA1 225/4885
US-20180099957-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF GPBAR1, SLC10A1, NR1H4 POLB 3719/4885HTR1D 2977/4885GABRA1 225/4885
US-11034684-B2 Isoxazole analogs as FXR agonists and methods of use thereof GPBAR1, SLC10A1, NR1H4 POLB 3719/4885HTR1D 2977/4885GABRA1 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.